# FDA 483 - St Joseph's Hospital of Atlanta, Inc. - June 06, 2025

Source: https://www.keypedia.com/records/483/st-josephs-hospital-of-atlanta-inc/caff5c06-b68c-4082-b8d2-71fae53b0cd8

> FDA 483 for St Joseph's Hospital of Atlanta, Inc. on June 06, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: St Joseph's Hospital of Atlanta, Inc.
- Inspection Date: 2025-06-06
- Product Type: biologics
- Office Name: FDA District Office — Atlanta, Georgia
- Summary: Emory Saint Joseph's Hospital of Atlanta, Inc. was inspected regarding its Transfusion Service. The inspection revealed a significant issue with record-keeping for emergency blood transfusions, specifically concerning the required physician signatures. This indicates a failure to adhere to established procedures for critical medical processes.

## Related Officers

- [Steven D. Banks](https://www.keypedia.com/people/steven-d-banks/30e4d016-e386-423d-9df8-1536cf43a0a3)

Company: https://www.keypedia.com/companies/st-josephs-hospital-of-atlanta-inc/08d0c611-52d8-48c4-9ae6-23ee5b85377b

Office: https://www.keypedia.com/offices/fda-district-office-atlanta-georgia/bae3b8c4-4161-4e9f-b5d1-e0e80b6abd43